Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic … BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ... Journal of clinical oncology 21 (24), 4642-4649, 2003 | 3099 | 2003 |
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2746 | 2020 |
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2352 | 2020 |
Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020 | 2032 | 2020 |
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease JJM Van Dongen, EA Macintyre, JA Gabert, E Delabesse, V Rossi, ... Leukemia 13 (12), 1901-1928, 1999 | 1563 | 1999 |
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia E Coustan-Smith, CG Mullighan, M Onciu, FG Behm, SC Raimondi, D Pei, ... The lancet oncology 10 (2), 147-156, 2009 | 1200 | 2009 |
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood JJM van Dongen, T Seriu, ER Panzer-Grümayer, A Biondi, ... The Lancet 352 (9142), 1731-1738, 1998 | 1199 | 1998 |
Childhood acute lymphoblastic leukemia: progress through collaboration CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ... Journal of Clinical Oncology 33 (27), 2938-2948, 2015 | 1076 | 2015 |
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the … V Conter, CR Bartram, MG Valsecchi, A Schrauder, R Panzer-Grümayer, ... Blood, The Journal of the American Society of Hematology 115 (16), 3206-3214, 2010 | 988 | 2010 |
Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 843 | 2021 |
Prenatal origin of acute lymphoblastic leukaemia in children JL Wiemels, G Cazzaniga, M Daniotti, OB Eden, GM Addison, G Masera, ... The Lancet 354 (9189), 1499-1503, 1999 | 813 | 1999 |
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial R Pieters, M Schrappe, P De Lorenzo, I Hann, G De Rossi, M Felice, ... The Lancet 370 (9583), 240-250, 2007 | 803 | 2007 |
IL-1 stimulates IL-6 production in endothelial cells. M Sironi, F Breviario, P Proserpio, A Biondi, A Vecchi, J Van Damme, ... Journal of immunology (Baltimore, Md.: 1950) 142 (2), 549-553, 1989 | 696 | 1989 |
Acute promyelocytic leukemia: from genetics to treatment F Grignani, M Fagioli, M Alcalay, L Longo, PP Pandolfi, E Donti, A Biondi, ... Blood 83 (1), 10-25, 1994 | 675 | 1994 |
Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy F Mandelli, D Diverio, G Avvisati, A Luciano, T Barbui, C Bernasconi, ... Blood, The Journal of the American Society of Hematology 90 (3), 1014-1021, 1997 | 653 | 1997 |
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases CM Niemeyer, M Arico, G Basso, A Biondi, AC Rajnoldi, U Creutzig, ... Blood, The Journal of the American Society of Hematology 89 (10), 3534-3543, 1997 | 567 | 1997 |
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study M Schrappe, MG Valsecchi, CR Bartram, A Schrauder, ... Blood, The Journal of the American Society of Hematology 118 (8), 2077-2084, 2011 | 565 | 2011 |
Biological and therapeutic aspects of infant leukemia A Biondi, G Cimino, R Pieters, CH Pui Blood, The Journal of the American Society of Hematology 96 (1), 24-33, 2000 | 561 | 2000 |
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international … T Flohr, A Schrauder, G Cazzaniga, R Panzer-Grümayer, ... Leukemia 22 (4), 771-782, 2008 | 537 | 2008 |
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 536 | 2021 |